Inhaled budesonide for acute mountain sickness.


In the present issue of the European Respiratory Journal, BERGER et al. [1] report the lack of efficacy of inhaled budesonide for the prevention of acute mountain sickness (AMS). This small well-designed study was undertaken to verify or refute the provocative finding of robust protection with budesonide against AMS reported by Chinese colleagues in 2014 [2… (More)
DOI: 10.1183/13993003.01355-2017


1 Figure or Table

Slides referencing similar topics